| Bioactivity | FPA-124, a cell-permeable copper complex, is a selective Akt inhibitor with an IC50 of 0.1 μM. FPA-124 interacts with both the pleckstrin homology (PH) and the kinase domains of Akt. FPA-124 induces apoptosis[1][2]. | |||||||||
| Invitro | FPA-124 exhibits dose-dependent growth inhibitory effects with IC50s of 7, 10, 34, and 55 μM in BT20, PC-3, COLO 357 and BxPC-3 cancer cell lines, respectively[1]. | |||||||||
| Name | FPA-124 | |||||||||
| CAS | 902779-59-3 | |||||||||
| Formula | C11H9Cl2CuN3O2S | |||||||||
| Molar Mass | 381.73 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
FPA-124
CAS: 902779-59-3 F: C11H9Cl2CuN3O2S W: 381.73
FPA-124, a cell-permeable copper complex, is a selective Akt inhibitor with an IC50 of 0.1 μM. FPA-124 interacts with b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.